Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 301 resources
-
Summary report: Hepatitis C good practice roadshow, Sheffield - October 2018
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Sheffield on 17th October 2018. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.England, Yorkshire and the Humber Reports & Research PDF -
Clinical Review of the Impacts of Hepatitis C: Short Life Working Group Report for the Scottish Government
This independent clinical review commissioned by the Scottish Government assesses the impacts of chronic hepatitis C infection on the health and wellbeing of individuals affected by contaminated blood and blood products. The review recommends that Scottish Infected Blood Support Scheme beneficiaries should be able to self-assess regarding the effect hepatitis C has had on their life, and which level of payment they are entitled to as a result. In October 2018, the Scottish Government confirmed it would accept the recommendations of this report.Scotland Reports & Research, Strategy & Planning PDF -
HCV Action and Public Health England hepatitis C roadshow in Kent: Presentations
HCV Action and Public Health England (PHE) staged the second hepatitis C good practice roadshow of 2018 in Maidstone on 5th September, bringing together 80 people from across Kent to discuss challenges to tackling hepatitis C and share solutions. The event was attended by clinicians, nurses, commissioners, drug and alcohol service workers, prison health professionals, and others working around hepatitis C in Kent.South East Other, Strategy & Planning PDF -
Summary report: Hepatitis C good practice roadshow, Kent - September 2018
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Maidstone on 5th September 2018. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.South East Reports & Research, Strategy & Planning PDF -
All Together Now: Our strategy to address the harms of alcohol and drugs in Scotland
The Scottish Government's draft strategy for tackling problematic alcohol and drug use, which contains recommendations related to hepatitis C, including routine BBV testing in drug services, alongside support accessing treatment for those diagnosed with hepatitis C.Scotland Strategy & Planning PDF -
Addaction Hepatitis C Strategy
Substance misuse service Addaction has produced a Hepatitis C Strategy, detailing the service's five-point plan for contributing to efforts to tackle hepatitis C.UK Strategy & Planning PDF -
Good practice case study: Edinburgh Access Practice outreach service
This HCV Action good practice case study focuses on Edinburgh Access Practice's outreach service, offering testing and treatment for hepatitis C to the homeless population. In the period from March 2014 to December 2016, of the 80 referrals received, 59 patients attended (70%) and 25 started treatment, compared with typical hospital clinical attendance rates of 30-50%. From January 2017 to June 2018 use of DAAs have enabled a further 52 patients to receive treatment at the EAP over the course of just 18 months.UK, Scotland Case study PDF -
Hepatitis C in the UK 2018 Report
Public Health England's annual 'Hepatitis C in the UK' report is the key national reporting document for hepatitis C. This is the tenth such report and follows the WHO Global Health Sector Strategy on Viral Hepatitis 2016 to 2021 and the draft action plan for the health sector response to viral hepatitis in the WHO European region. The report is structured to support UK monitoring of the Global Health Sector Strategy goals and summarises the impact of UK action plans to drive down mortality from HCV and reduce the number of new infections.UK Reports & Research, Strategy & Planning PDF -
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
This research paper assesses the impact of (i) incentives for R&D based on providing Intellectual Property (IP) rights protection, (ii) market competition and (iii) other factors including healthcare policies on access to direct acting antivirals (DAA) for hepatitis C in Europe.UK, Rest of World Reports & Research PDF -
Public health guidance on active case finding of communicable diseases in prison settings
This document, produced by the European Centre for Disease Prevention and Control, provides guidance to EU/EEA member states on prevention and case-finding for communicable diseases, including hepatitis C, in prisons.UK, Rest of World Reports & Research, Strategy & Planning PDF